Strides Arcolab Ltd. posted first-quarter Stand-Alone net profit of Rs.31.57 crore or Rs.5.32 per share, compared with a net loss of Rs.28.16 crore or Rs.6.21 per share in the corresponding quarter of the preceding year.
Net income from operations rose by 34 percent to Rs.161.34 crore from the Rs.120.42 crore in the year-ago quarter, while other operating income totaled Rs.17.02 crore, compared with Rs.10.96 crore in Q1FY12.
Vice Chairman and Group CEO Arum Kumar said, "Year 2013 has started on a promising note and we continue to be upbeat about our pharma business which is currently tracking ahead of guidance."
He added, "the quarter also witnessed focused effort on growing the biotech business through new exciting partnerships."
At the BSE, Strides Arcolab shares are currently trading at Rs.822, up 0.09 percent from the previous close.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.